期刊文献+

SUMO特异性蛋白酶1对hPXR调控P-gp基因表达的影响

Effects of SUMO specific protease 1 on h PXR-mediated P-gp gene expression
原文传递
导出
摘要 孕烷X受体(pregnane X receptor,PXR)属于核受体(nuclear receptors,NRs)超家族的一员,是一个配体依赖性的转录调节因子[1]。配体激活后的PXR进入细胞核,与视黄醛X受体(retinoid X receptor,RXR)形成异二聚体,随后结合到靶基因的PXR反应元件上,进而介导该基因的转录表达。PXR下游靶基因的表达产物主要是一类与外源性药物及内源性物质代谢转运相关的酶及蛋白,包括I相代谢酶如细胞色素P450同工酶家族中的CYP3A、CYP2B和CYP2C。II相代谢酶如尿苷二磷酸葡萄糖醛酸转移酶基因(UGT)和谷胱甘肽S转移酶(GST),III相药物转运蛋白如P-糖蛋白(p-gP)、多药耐药相关蛋白(MRP)和乳腺癌耐药蛋白(BCRP)等。 The study aimed to investigate the effects of small ubiquitin-related modifier(SUMO) specific protease 1(SENP1) on human PXR-mediated MDR1 transcriptional activity and m RNA expression. Empty vector and expression plasmids, including PXR, SENP1 and SENP1 mutant(SENP1m) were transiently transfected into Hep G2 and LS174 T cells using Lipo2000. Transcriptional activity was detected by dual luciferase reporter gene assay, and m RNA level was measured using real-time polymerase chain reaction. The results showed that SENP1 could remarkably reduce the rifampicin(RIF)-induced MDR1 reporter activity and m RNA level in h PXR over expressed Hep G2 and LS174 T cells(P〈0.05), whereas adding SENP1 m restored the RIF-induced increases(P〈0.05). These results indicated that SENP1 could repress the RIF-induced h PXR-mediated MDR1 transcriptional activity and m RNA expression.
出处 《药学学报》 CAS CSCD 北大核心 2015年第9期1192-1196,共5页 Acta Pharmaceutica Sinica
基金 国家自然科学基金资助项目(81402998)
关键词 孕烷X受体 P-糖蛋白 小类泛素化蛋白 SUMO特异性蛋白酶1 pregnane X receptor P-glycoprotein SUMO protein SUMO specific protease 1
  • 相关文献

参考文献13

  • 1Kliewer SA, Moore JT, Wade L, et al. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway [J]. Cell, 1998, 92: 73-82.
  • 2Xu C, Li CY, Kong AN. Induction of phase I, II and III drug metabolism/transport by xenobiotics [J]. Arch Pharm Res, 2005, 28: 249-268.
  • 3Hannoun Z, Greenhough S, Jaffray E, et al. Post-translational modification by SUMO [J]. Toxicology, 2010, 278:288 -293.
  • 4Schneider Aguirre R, Karpen SJ. Inflammatory mediators increase SUMOylation of retinoid X receptor ct in c-Jun N-terminal kinase-dependent manner in human hepatocellular carcinoma cells [J]. Mol Pharmacol, 2013, 84: 218-226.
  • 5Yamashita D, Yamaguchi T, Shimizu M, et al. The transactivating function of peroxisome proliferator-activated receptor y is negatively regulated by SUMO conjugation in the amino-terminal domain [J]. Genes Cells, 2004, 9: 1017- 1029.
  • 6Pourcet B, Pineda-Torra I, Derudas B, et al. SUMOylation of human peroxisome proliferator-activated receptor a inhibits its trans-activity through the recruitment of the nuclear corepressor NCoR [J]. J Biol Chem, 2010, 285:5983 -5992.
  • 7Lee JH, Park SM, Kim OS, et al. Differential SUMOylation of LXRa and LXR: mediates transrepression of STAT1inflammatory signaling in IFN-y-stimulated brain astrocytes [J]. Mol Cell, 2009, 35: 806-817.
  • 8Flu G, Xu C, Staudinger JL. Pregnane X receptor is SUMOylated to repress the inflammatory response [J]. J Pharmacol Exp Ther, 2010, 335:342-350.
  • 9Choi SJ, Chung SS, Rho EJ, et al. Negative modulation of RXRa transcriptional activity by small ubiquitin-related modifier (SUMO) modification and its reversal by SUMO- specific protease SUSP1 [J]. J Biol Chem, 2006, 281: 30669-30677.
  • 10Chung SS, Ahn BY, Kim M, et al. SUMO modification selectively regulates transcriptional activity of peroxisome-proliferator-activated receptor y in C2C12 myotubes [J]. Biochem J, 2011,433: 155-161.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部